Evidence map›Paper›PMID 38352334›Full record

ArticlebioRxiv : the preprint server for biology2024

Histone variant H2BE enhances chromatin accessibility in neurons to promote synaptic gene expression and long-term memory.

Emily R Feierman, Sean Louzon, Nicholas A Prescott, Tracy Biaco, Qingzeng Gao, Qi Qiu, Kyuhyun Choi, Katherine C Palozola, Anna J Voss, Shreya D Mehta and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Emily R FeiermanNeuroscience Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0002-2133-5825
Sean LouzonCell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Nicholas A PrescottChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Tracy BiacoChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Qingzeng GaoChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Qi QiuDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Kyuhyun ChoiDepartment of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Katherine C PalozolaDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Anna J VossNeuroscience Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Shreya D MehtaDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Camille N QuayeDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Katherine T LynchDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Marc V FuccilloDepartment of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Hao WuDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Yael DavidChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY.
Erica KorbDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Translational Therapeutics (United States) · USMemorial Sloan Kettering Cancer Center · USCalifornia University of Pennsylvania · USUniversity of Pennsylvania · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBERTS, TIMOTHY P · 2016 to 2020
$6.3M
The epigenetic encoding of learning and memoryDP2MH129985 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2021 to 2024
$2.4M
Investigating histone glycation as a new dynamic epigenetic markR35GM138386 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI DAVID-SHTERNBERG, YAEL E · 2020 to 2024
$2.2M
The Histone Code of Neuronal Function and DysfunctionR00MH111836 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2019 to 2021
$745k
Biochemical studies of aberrant chromatin regulation in cancerF99CA264420 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PRESCOTT, NICHOLAS · 2021 to 2022
$94k
Uncovering the function of histone variant H2BE in neuronsF31MH126576 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI FEIERMAN, EMILY RUTH · 2022 to 2023
$82k
NCI NIH HHS F99 CA264420NCI NIH HHS P30 CA008748NICHD NIH HHS U54 HD086984NIGMS NIH HHS R35 GM138386NIMH NIH HHS DP2 MH129985NIMH NIH HHS F31 MH126576NIMH NIH HHS R00 MH111836
6 · The paper itself

Abstract

Regulation of histone proteins affects gene expression through multiple mechanisms including exchange with histone variants. However, widely expressed variants of H2B remain elusive. Recent findings link histone variants to neurological disorders, yet few are well studied in the brain. We applied new tools including novel antibodies, biochemical assays, and sequencing approaches to reveal broad expression of the H2B variant H2BE, and defined its role in regulating chromatin structure, neuronal transcription, and mouse behavior. We find that H2BE is enriched at promoters and a single unique amino acid allows it to dramatically enhance chromatin accessibility. Lastly, we show that H2BE is critical for synaptic gene expression and long-term memory. Together, these data reveal a novel mechanism linking histone variants to chromatin regulation, neuronal function, and memory. This work further identifies the first widely expressed H2B variant and uncovers a single histone amino acid with profound effects on genomic structure.

Identifiers

PMID38352334
PMCPMC10862743
OpenAlexW4391353125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.